Analysis of Cross-Association between mRNA Expression and RNAi Efficacy for Predictive Target Discovery in Colon Cancers

The availability of large-scale, collateral mRNA expression and RNAi data from diverse cancer cell types provides useful resources for the discovery of anticancer targets for which inhibitory efficacy can be predicted from gene expression. Here, we calculated bidirectional cross-association scores (...

Full description

Bibliographic Details
Main Authors: Euna Jeong, Yejin Lee, Youngju Kim, Jieun Lee, Sukjoon Yoon
Format: Article
Language:English
Published: MDPI AG 2020-10-01
Series:Cancers
Subjects:
Online Access:https://www.mdpi.com/2072-6694/12/11/3091
_version_ 1797550053910380544
author Euna Jeong
Yejin Lee
Youngju Kim
Jieun Lee
Sukjoon Yoon
author_facet Euna Jeong
Yejin Lee
Youngju Kim
Jieun Lee
Sukjoon Yoon
author_sort Euna Jeong
collection DOAJ
description The availability of large-scale, collateral mRNA expression and RNAi data from diverse cancer cell types provides useful resources for the discovery of anticancer targets for which inhibitory efficacy can be predicted from gene expression. Here, we calculated bidirectional cross-association scores (predictivity and descriptivity) for each of approximately 18,000 genes identified from mRNA and RNAi (i.e., shRNA and sgRNA) data from colon cancer cell lines. The predictivity score measures the difference in RNAi efficacy between cell lines with high vs. low expression of the target gene, while the descriptivity score measures the differential mRNA expression between groups of cell lines exhibiting high vs. low RNAi efficacy. The mRNA expression of 90 and 74 genes showed significant (<i>p</i> < 0.01) cross-association scores with the shRNA and sgRNA data, respectively. The genes were found to be from diverse molecular classes and have different functions. Cross-association scores for the mRNA expression of six genes (<i>CHAF1B, HNF1B, HTATSF1, IRS2, POLR2B</i> and <i>SATB2</i>) with both shRNA and sgRNA efficacy were significant. These genes were interconnected in cancer-related transcriptional networks. Additional experimental validation confirmed that siHNF1B efficacy is correlated with <i>HNF1B</i> mRNA expression levels in diverse colon cancer cell lines. Furthermore, <i>KIF26A</i> and <i>ZIC2</i> gene expression, with which shRNA efficacy displayed significant scores, were found to correlate with the survival rate from colon cancer patient data. This study demonstrates that bidirectional predictivity and descriptivity calculations between mRNA and RNAi data serve as useful resources for the discovery of predictive anticancer targets.
first_indexed 2024-03-10T15:23:00Z
format Article
id doaj.art-c5f9ca07aba74011bba6652480e5cdb7
institution Directory Open Access Journal
issn 2072-6694
language English
last_indexed 2024-03-10T15:23:00Z
publishDate 2020-10-01
publisher MDPI AG
record_format Article
series Cancers
spelling doaj.art-c5f9ca07aba74011bba6652480e5cdb72023-11-20T18:18:39ZengMDPI AGCancers2072-66942020-10-011211309110.3390/cancers12113091Analysis of Cross-Association between mRNA Expression and RNAi Efficacy for Predictive Target Discovery in Colon CancersEuna Jeong0Yejin Lee1Youngju Kim2Jieun Lee3Sukjoon Yoon4Research Institute of Women’s Health, Sookmyung Women’s University, Seoul 04310, KoreaDepartment of Biological Sciences, Sookmyung Women’s University, Seoul 04310, KoreaDepartment of Biological Sciences, Sookmyung Women’s University, Seoul 04310, KoreaDepartment of Biological Sciences, Sookmyung Women’s University, Seoul 04310, KoreaResearch Institute of Women’s Health, Sookmyung Women’s University, Seoul 04310, KoreaThe availability of large-scale, collateral mRNA expression and RNAi data from diverse cancer cell types provides useful resources for the discovery of anticancer targets for which inhibitory efficacy can be predicted from gene expression. Here, we calculated bidirectional cross-association scores (predictivity and descriptivity) for each of approximately 18,000 genes identified from mRNA and RNAi (i.e., shRNA and sgRNA) data from colon cancer cell lines. The predictivity score measures the difference in RNAi efficacy between cell lines with high vs. low expression of the target gene, while the descriptivity score measures the differential mRNA expression between groups of cell lines exhibiting high vs. low RNAi efficacy. The mRNA expression of 90 and 74 genes showed significant (<i>p</i> < 0.01) cross-association scores with the shRNA and sgRNA data, respectively. The genes were found to be from diverse molecular classes and have different functions. Cross-association scores for the mRNA expression of six genes (<i>CHAF1B, HNF1B, HTATSF1, IRS2, POLR2B</i> and <i>SATB2</i>) with both shRNA and sgRNA efficacy were significant. These genes were interconnected in cancer-related transcriptional networks. Additional experimental validation confirmed that siHNF1B efficacy is correlated with <i>HNF1B</i> mRNA expression levels in diverse colon cancer cell lines. Furthermore, <i>KIF26A</i> and <i>ZIC2</i> gene expression, with which shRNA efficacy displayed significant scores, were found to correlate with the survival rate from colon cancer patient data. This study demonstrates that bidirectional predictivity and descriptivity calculations between mRNA and RNAi data serve as useful resources for the discovery of predictive anticancer targets.https://www.mdpi.com/2072-6694/12/11/3091gene expressionshRNA screeningCRISPRanticancer targetsbiomarkersprecision medicine
spellingShingle Euna Jeong
Yejin Lee
Youngju Kim
Jieun Lee
Sukjoon Yoon
Analysis of Cross-Association between mRNA Expression and RNAi Efficacy for Predictive Target Discovery in Colon Cancers
Cancers
gene expression
shRNA screening
CRISPR
anticancer targets
biomarkers
precision medicine
title Analysis of Cross-Association between mRNA Expression and RNAi Efficacy for Predictive Target Discovery in Colon Cancers
title_full Analysis of Cross-Association between mRNA Expression and RNAi Efficacy for Predictive Target Discovery in Colon Cancers
title_fullStr Analysis of Cross-Association between mRNA Expression and RNAi Efficacy for Predictive Target Discovery in Colon Cancers
title_full_unstemmed Analysis of Cross-Association between mRNA Expression and RNAi Efficacy for Predictive Target Discovery in Colon Cancers
title_short Analysis of Cross-Association between mRNA Expression and RNAi Efficacy for Predictive Target Discovery in Colon Cancers
title_sort analysis of cross association between mrna expression and rnai efficacy for predictive target discovery in colon cancers
topic gene expression
shRNA screening
CRISPR
anticancer targets
biomarkers
precision medicine
url https://www.mdpi.com/2072-6694/12/11/3091
work_keys_str_mv AT eunajeong analysisofcrossassociationbetweenmrnaexpressionandrnaiefficacyforpredictivetargetdiscoveryincoloncancers
AT yejinlee analysisofcrossassociationbetweenmrnaexpressionandrnaiefficacyforpredictivetargetdiscoveryincoloncancers
AT youngjukim analysisofcrossassociationbetweenmrnaexpressionandrnaiefficacyforpredictivetargetdiscoveryincoloncancers
AT jieunlee analysisofcrossassociationbetweenmrnaexpressionandrnaiefficacyforpredictivetargetdiscoveryincoloncancers
AT sukjoonyoon analysisofcrossassociationbetweenmrnaexpressionandrnaiefficacyforpredictivetargetdiscoveryincoloncancers